The Y-90 resin microspheres demonstrated a 98.5% best overall objective response rate, with all patients responding to the treatment.

Having detectable ctDNA before treatment is associated with worse outcomes among patients with mCRPC, regardless of the treatment they receive.

A cooperative model may at time better serve the relationship between patient and clinician.

This study examined the posttreatment experiences of 7 children with brain tumor to determine whether problems with cognition, body function, and social functioning improved over time.

These data support the use of sacituzumab plus pembrolizumab as a potential new standard of care,” said Sara Tolaney, MD.

Investigators examined survival outcomes and recurrence patterns by pathologic nodal status in patients with upper tract urothelial carcinoma (UTUC) receiving neoadjuvant chemotherapy.

Many young adult survivors of childhood hematologic cancer do not have comprehensive survivorship care summaries or believe they need one.

The proportion of patients who receive a long-term opioid prescription following colorectal surgery has significantly decreased over time.

A distinct natural killer (NK) cell subset, termed CLL_NK, is a precursor to effector NK phenotypes and serves as a critical immunologic marker in chronic lymphocytic leukemia (CLL), offering ...

The albumin-bilirubin (ALBI) score can independently predict prognosis in post-surgical patients with distal cholangiocarcinoma (dCCA), a form of cholangiocarcinoma (CCA), according to results ...

HealthDay News — Women with cardiovascular disease (CVD) have a substantially higher adiposity-associated risk for breast cancer, according to a study published online July 7 in Cancer.

III/IV resectable melanoma remained event-free at four years from the start of neoadjuvant systemic treatment.